Fox Business - The Power to Prosper
Search Site

Regeneron Pharmaceuticals

Related Topics

  1. King Pharmaceuticals
  2. Pharmaceuticals
  3. Vertex Pharmaceuticals
  4. Sanofi S.A.
  5. Amylin Pharmaceuticals
  6. Watson Pharmaceuticals
Get updates on Regeneron Pharmaceuticals
Market Wrap for Thursday, June 6: Stocks Reverse Mid-Day; Rally to Close at Session Highs

The U.S. stock market surged on Thursday after an afternoon rally lifted the major averages out of negative territory.Stocks closed near their best levels of the session, with the Dow adding around 80 points. Around mid-day, the market appeared to be in danger of adding to its recent losses, and a washout was not out of the question.A sharply declining U.S. dollar, however, triggered risk appetite across asset classes. The rally will certainly be viewed as a positive development by investors who have been beaten up over the last 5 trading days amid a correction in share prices.Major AveragesThe Dow Jones Industrial Average climbed around 80 points, or 0.53 percent, to finish at 15,041.The S&P 500 added almost 14 points, or 0.85 percent, to just above 1,622.The Nasdaq rose almost 23 points, or 0.66 percent, to 3,424.Jobless ClaimsInitial jobless claims fell to 346,000 for the week ending June 1 from 357,000 for the week ending May 25. This compared to consensus estimates calling for ini...

Read More ›

  1. EUROPE MARKETS: Europe Stocks Rally As German ZEW Index Posts Rise

    European stock markets posted broad-based gains on Tuesday, boosted by stronger-than-expected German investor-sentiment data, while shares of Danone SA were among ma...

  2. EUROPE MARKETS: Europe Stocks Rise After German ZEW Report

    European stock markets posted broad-based gains on Tuesday, boosted by stronger-than-expected German economic-sentiment data, with shares of Danone SA among major ad...

  3. Bayer, Regeneron to Launch New Phase III Study for VEGF Trap-Eye

    Bayer HealthCare and Regeneron Pharmaceuticals, Inc. said Tuesday they initiated a new Phase III trial of VEGF Trap-Eye in the treatment of Diabetic Macular Edema in...

  4. ADR Shares Close Mixed As Novo Nordisk Drops On FDA News

    International companies trading in New York closed mixed Monday, as Novo Nordisk AS (NVO, NOVO-B.KO) led European stocks lower, while most Asian markets were closed ...

  5. Sanofi boosting stake in Regeneron

    French drugmaker Sanofi SA is buying more shares in U.S. biotech company Regeneron Pharmaceuticals Inc , its partner in the development of potential blockbuster trea...

  6. Regeneron says Sanofi to boost stake in its shares

    Regeneron Pharmaceuticals Inc said its longtime drug-development partner Sanofi SA aims to boost its stake in the U.S. biotechnology company through open market purc...

  7. EUROPE MARKETS: Novo Nordisk Leads Europe Lower After FDA News

    Novo Nordisk AS on Monday knocked the air out of Europe's benchmark stock index after a setback in the U.S., while the region's bourses saw mixed trade as a meeting ...

  8. Regeneron says Sanofi plans to buy shares

    Regeneron Pharmaceuticals Inc on Monday said it has received notice that Sanofi SA intends to acquire Regeneron's common stock through open market purchases and dire...

  9. Regeneron Shares Jump On Sanofi Share Buy Plan

    Shares of Regeneron Pharmaceuticals Inc. were up 8% to $179 in early trading Monday after French drug maker Sanofi SA announced its intention to purchase a piece of ...

  10. Regeneron : Sanofi Plans to Increase Stake to Over $500 Million of Stock

    Regeneron Pharmaceuticals Inc. (REGN) said Sanofi S.A. (SNY, SAN.FR) notified the biopharmaceutical company of its intent to boost its investment in the company and ...

  11. J&J Delays Plans for Arthritis Drug

    Johnson & Johnson (JNJ) has delayed plans to seek regulatory clearance for an experimental arthritis treatment because of a continuing U.S. moratorium on most clinic...

  12. J&J Delays Plans for Arthritis Drug as FDA Continues Hold on Testing

    Johnson & Johnson (JNJ) has delayed plans to seek regulatory clearance for an experimental arthritis treatment because of a continuing U.S. moratorium on most clinic...

  1. Regeneron -Sanofi Asthma Drug Shows Promising Early Results

    An experimental drug being developed by Regeneron Pharmaceuticals Inc. (REGN) and Sanofi SA (SNY) showed promising results during a small, mid-stage clinical trial i...

  2. Market Wrap for Friday, May 3: Stocks Jump on Strong Jobs Data

    The U.S. stock market jumped on Friday to end the trading week. The catalyst for the move higher was a strong jobs report, which briefly sent the Dow Jones Industria...

  3. Allergan Reports Drug Development Delay, Lower Profits

    Allergan Inc. (AGN) said it won't advance two of its key pipeline drugs into late stage trials needed for regulatory approval as quickly as it had hoped, sending the...

  4. Market Wrap for Wednesday, May 1: Stocks Fall as Employment Data Weakens in April

    The U.S. stock market was hit hard on Wednesday as investors reacted to a report which showed slowing employment conditions for the month of April.The losses were al...

  5. Regeneron Pharmaceuticals Co-Founder Receives $81.55 Million Compensation

    Regeneron Pharmaceuticals Inc.'s (REGN) stock price tripled last year, and the compensation of co-founder and Chief Executive Leonard Schleifer nearly did, too.Mr. S...

  6. Regeneron to Join S&P 500 After MetroPCS Merger with T-Mobile

    Standard & Poor's said it will add biopharmaceutical company Regeneron Pharmaceuticals Inc. (REGN) to the S&P 500 index, replacing MetroPCs Communications Inc. (PCS)...

  7. Sanofi and Regeneron See Positive Results From Atopic Dermatitis Drug Studies

    Sanofi (SNY) and Regeneron Pharmaceuticals Inc. (REGN) said results from two studies of its treatment for atopic dermatitis were positive.The drug companies said poo...

‹ Prev123Next ›
Freebase CC-BY
Source: Regeneron Pharmaceuticals on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL